Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company, Inc. (GCAND) EBITDA Margin (2017 - 2021)

Greater Cannabis Company (GCAND) has 4 years of EBITDA Margin data on record, last reported at 170.47% in Q2 2020.

  • For Q2 2020, EBITDA Margin changed N/A year-over-year to 170.47%; the TTM value through Mar 2021 reached 609.01%, up 675536.0%, while the annual FY2021 figure was 2716.91%, 210402.0% down from the prior year.
  • EBITDA Margin reached 170.47% in Q2 2020 per GCAND's latest filing, up from 4327.33% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 70607.6% in Q1 2017 and bottomed at 28856.62% in Q3 2017.
  • Average EBITDA Margin over 4 years is 4661.2%, with a median of 168.38% recorded in 2018.
  • The widest YoY moves for EBITDA Margin: up -326338bps in 2018, down -7050808bps in 2018.
  • A 4-year view of EBITDA Margin shows it stood at 28856.62% in 2017, then skyrocketed by 99bps to 166.29% in 2018, then tumbled by -2502bps to 4327.33% in 2019, then skyrocketed by 96bps to 170.47% in 2020.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 170.47% in Q2 2020, 4327.33% in Q4 2019, and 2993.85% in Q3 2019.